The basic domain of Tat is required for trans-activation of viral gene expression. We have performed scanning peptide studies to demonstrate that only this domain is capable of binding to the TAR RNA stem-loop. Strikingly, the basic domain of the other human Immunodeficiency virus trans-acting factor, Rev, but no other region, is also capable of binding to TAR. Peptide derivatives of Tat do not require the highly conserved glutamine residue at position 54 for TAR binding, since it may be substituted or deleted. In addition, the two lysine residues may be replaced by argies. Analysis of binding and trans-activation demonstrated that homopolymers of arginine can completely substitute for the basic domain.
nine arginines substituting for the basic domain of Tat enable full trans-activation in vivo. Homopolymers of at least seven arginines are required for detectable in vitro complex formation, although -30% trans-activation is achieved with a mutant Tat containing only five arginines.
The viral trans-activator protein Tat (1, 2) is essential for replication of the human immunodeficiency virus type 1 (HIV-1) (3, 4) . It exhibits both transcriptional and posttranscriptional stimulatory effects on viral gene expression (for recent reviews, see refs. 5 and 6). The cis-acting target sequence (TAR), which confers responsiveness to Tat, is located in the viral 5' long terminal repeat (LTR) (7) between nucleotides +18 and +44 (8) (9) (10) (11) , although sequences extending to nucleotide +52 are necessary for the full transactivation response (12) . Nuclease mapping studies demonstrated that RNAs comprising the TAR region fold into a stable stem-oop structure (13) . Primary sequence and RNA secondary structure requirements for TAR function include an intact stem, the sequence of the loop, and a 3-nucleotide bulge at positions +23 to +25 (10, 12, 14, 15) . These findings and other studies (16) suggested that the TAR element is recognized as RNA. In agreement with this, the specific interaction ofTat with TAR RNA was recently demonstrated using RNA mobility-shift studies and filter-binding assays (17) (18) (19) (20) . This interaction is sequence and structure specific and correlates with Tat-mediated trans-activation (18, 19) . In particular, an invariant uridine residue at position +23 of TAR was found to be critical for binding in vitro (18, 21) and for trans-activation (18) . However, the binding ofTat to TAR RNA is not sufficient by itselfto account for trans-activation. Indeed, substitutions in the loop sequence that abolish transactivation (12, 14, 15) did not affect the interaction between Tat and TAR RNA. The loop sequence has been shown to serve as a recognition site for cellular factors (22, 23) . These interactions have been proposed to be important for the trans-activation response (22) (23) (24) .
Mutational analysis of the tat gene has revealed several domains required for trans-activation: an acidic, a cysteinerich, and a basic domain (25) (26) (27) (28) (29) . The acidic domain is present at the amino terminus of the protein and has been proposed to function as an activation domain, in analogy with transcriptional activators (30) . The cysteine-rich domain (containing seven cysteines between amino acids 22 and 37) is involved in the formation of metal-linked dimers, although it remains to be established whether dimer formation is necessary for Tat function (31, 32) . The possibility that the acidic and cysteine-rich domains interact with important effectors of trans-activation is supported by a recent study demonstrating that a trans-dominant negative phenotype exhibited by a Tat protein truncated at the carboxyl end is dependent on the integrity of these regions (33) .
The basic domain (two lysines and six arginines between amino acids 49 and 57) mediates subcellular localization of Tat to the nucleus, with preferential accumulation in the nucleolus (34, 35) . Moreover, this positively charged domain is responsible for the interaction with TAR RNA, inasmuch as short peptides comprising this domain bind efficiently and specifically to TAR RNA (18, 20, 21) . In this study, we analyzed the amino acid requirements within the basic region of Tat necessary for the interaction with TAR RNA in vitro and for trans-activation in vivo.
MATERIALS AND METHODS
Peptides. Peptide Tat (amino acids 47-58) was a generous gift from Alan Frankel (Whitehead Institute, Cambridge, MA). All other peptides (except those in Fig. 2 ) were purchased from the American Peptide Company (Santa Clara, CA) and were >98% pure. Peptides used for Fig. 2 were kindly provided by American Biotechnologies (Cambridge, MA).
In Vitro Transcription and Chemical Synthesis of TAR RNAs. All RNAs comprising nucleotides +18 to +44 of TAR were prepared from oligodeoxynucleotide templates by in vitro transcription (except for Fig. 2 ) using T7 RNA polymerase as described (36) , except the GTP concentration was raised to 0.5 mM. The mutant TAR RNA used in the experiments in Fig. 5 had a uridine +23 to adenosine substitution that has been shown to abrogate complex formation with Tat (18) . The transcripts were purified on an 8% polyacrylamide/8 M urea gel, eluted in a solution containing 0.5 M ammonium acetate, 1 mM EDTA, and 0.1% SDS (38) , and recovered by phenol/chloroform extraction followed by eth-6235 anol precipitation. For Fig. 2 , synthetic oligoribonucleotides consisting of nucleotides +18 to +44 were prepared according to the method of Usman et al. (39) .
RNA Mobility-Shift Assay. The RNA mobility-shift assay was performed as described except that the glycerol concentration in the incubation reaction mixture was raised to 5% (18 (42) . Cell extracts were prepared 40-48 hr after transfection by freeze-thawing three times, heating 7 min at 60°C, and microcentrifuging for 5 min. CAT assays were performed with 5 or 25 ,ug of cell extract for 1 hr at 37°C as described (43 one complex was formed even at 500-fold molar excess, indicating only one binding site on the RNA. These data demonstrate that the domain of Tat required for the formation of nucleoprotein complexes with TAR RNA can be delimited to a stretch of 10 amino acids representing the basic domain of Tat.
The essential HIV-1 trans-regulator Rev (44, 45) contains a basic domain similar to Tat. This arginine-rich sequence was proposed to be the site of interaction between Rev and its cis-acting target RNA, termed RRE (46, 47) . Interestingly, the substitution of the basic region of Tat (amino acids 49-58) by the 15-amino acid basic region of Rev did not significantly affect trans-activation activity of the chimeric protein or its subcellular localization (27, 28) . This functional substitution is possibly due to the capacity of the basic domain ofRev to bind TAR RNA. To address this possibility, we tested a peptide comprising the basic domain (amino acids [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] of Rev in the RNA mobility-shift assay (Fig. 1, lanes 8-10) . Although this peptide has only partial homology to the Tat basic domain, it bound TAR RNA as efficiently as the basic Tat peptides assayed above (compare lanes 8-10 with lanes 5-7).
Only Peptides Containing an Intact Basic Domain of Tat or Rev Bind TAR RNA. Before pursuing the analysis of the amino acids in Tat that are necessary for interaction with TAR RNA, it was important to determine whether other regions of Tat and Rev could interact independently with TAR RNA. To this end, we analyzed a series of peptides that encompass the entire Tat and Rev proteins for their ability to bind TAR RNA (Fig. 2) . Only two peptides originating from Tat and Rev were capable of complexing with TAR RNA. These peptides contained the entire basic domains of Tat and Rev [ Fig. 2A To test the model of hydrogen bonding, we changed the glutamine residue in the Tat peptide (amino acids 47-58) (YGRKKRRQRRRP) to glycine, cysteine, serine, histidine, or lysine. When tested in the RNA mobility-shift assay most of these peptides formed complexes with TAR RNA with efficiencies comparable to that of the wild-type peptide (Fig.  3) . Substitution of a cysteine residue for glutamine-54 resulted in a reduction in complex formation of U4fold (compare lanes 2 and 3 with lanes 6 and 7).: This reduction could be due to the aberrant dimerization of-the peptide caused by the formation of disulfide-bonds. Substitution of the basic amino acid lysine for glutamine-54 stimulated complex formation *2-fold (compare.lanes 2 and 3 with lanes 12 and 13).
Binding of the substituted peptides to TAR RNA was specific inasmuch as it did not occur with TAR RNA, in which the invariant uridine residue in the bulge was substituted for the nonfunctional adenosine (data shown only for lysine substitution; lanes 14 and 15). Taken together, these results argue against the possibility that the side chain of glutamine-54 is the donor and/or acceptor of a hydrogen bond from uridine +23 (or another nucleotide).
To examine the possibility that the position of glutamine in the basic region is important, perhaps to charge distribution in the peptide, we generated a series of peptides composed of eight arginines and one glutamine at different positions along the peptide (Fig. 4) . All of these peptides bound specifically to wild-type TAR RNA, but not to the mutant TAR RNA (Fig. 4) We also changed single or pairs of arginine residues to evaluate the effect of decreasing the number of charged amino acids within the basic domain ( Table 1 ). The following mutations were introduced: (i) arginine-55 to glutamine (R55Q), (ii) both arginine-52 and -53 to glutamine (R52Q,R53Q), (iii) both arginine-55 and -56 to glutamine (R55Q,R56Q). Substituting glutamine for arginine-55 did not reduce trans-activation significantly. Substituting two glutamines for arginine-55 and -56 reduced trans-activation 14-fold. Strikingly, trans-activation was nearly abolished (200-fold reduction) by changing arginine-52 and -53 to glutamine residues. Thus, the mutation of arginine-52 and -53 has a much stronger effect on trans-activation than the substitution of arginine-55 and -56, suggesting that the posi- tion of the positively charged amino acids within the basic domain is significant for the activity of Tat.
At Least Six Arginines Are Required for Full TransActivation Activity of Tat. To determine whether the net charge of the basic domain affects trans-activation, we replaced the basic stretch of Tat (amino acids 49-57) by nine, eight, seven, six, or five arginine residues. The transactivation efficiency of mutant Tat proteins with six to nine arginine residues was comparable to that of the wild-type protein (Table 1) . However, a 3-fold reduction in Tat activity was observed when five arginine residues substituted for the basic domain. These data suggest that a minimum of six arginine residues is necessary for the full trans-activation response. Taken together, the results suggest a qualitative correlation between the binding data and the trans-activation results. 
DISCUSSION
In this study, we present evidence that the interaction between Tat and TAR RNA is dependent on the number of charged amino acids within the basic domain of Tat. Moreover, our data suggest that in addition to the net positive charge the positioning of the basic amino acids is also important.
The trans-activation efficiency of two mutant proteins having the same number of charged amino acids within the basic domain was strongly dependent on which of the arginine residues was changed. The substitution of glutamine residues for arginine-52 and -53 abolished trans-activation, while Tat activity could still be detected when arginine-55 and -56 were mutated. The observation that arginine-52 and -53 are critical for trans-activation is consistent with the finding that Tat peptides in which arginine-52 and -53 were mutated to alanines could not bind to TAR RNA (49) .
Our data are also consistent with previous reports on the effects of single and multiple mutations in the basic stretch on Tat activity. Single mutations in the basic domain had minimal effects on Tat activity: these include the following mutations: R49T (50) residues is necessary for efficient binding to TAR RNA. However, a Tat protein containing only five arginines is still functional in vivo, albeit with reduced efficiency. This could be explained by a stabilization of the Tat-TAR interaction through TAR RNA-specific cellular proteins (22) (23) (24) . One of these proteins has been implicated in Tat function as it increases Tat-mediated transcription in vitro (49) . The stabilization of Tat-TAR RNA complexes in vivo is also consistent with a previous report demonstrating residual transactivation activity with mutant TAR RNAs that did not form detectable complexes with Tat in vitro (18) . This suggests that our in vitro assay detects only strong interactions. If, as we predict, Tat protein containing a five-arginine stretch forms a weak complex with TAR RNA, it is apparently unstable under our gel electrophoresis conditions.
The exact role of the basic residues in the interaction with TAR RNA remains to be elucidated. Based on the results presented in this study, the following mechanism of recognition is proposed. The binding of Tat to TAR RNA could be mediated through an electrostatic interaction of the basic residues with phosphates in the RNA backbone. The specificity of this interaction could be conferred by a precise tertiary structure in the RNA that requires a bulge of at least 2 unpaired bases, in which the 5'-most base must be a uridine (18) . Results obtained from the mutation of arginine residues within the basic domain seem to point to arginine-52 and -53 as key elements for trans-activation. Either of them could participate in a specific hydrogen bond with uridine +23. It is unlikely that the highly conserved glutamine-54 residue provides specificity to the Tat-TAR interaction, since it can be substituted or deleted without significantly affecting transactivation activity.
There is a precedent for an interaction between stretches of arginine residues and RNA. Protamines are postulated to consist of three or four a-helical domains. Each a-helical domain contains at least four arginine residues that bind to the double-stranded portion of tRNAs (52) . A complete understanding of the interaction between Tat and TAR RNA will certainly require the elucidation of the crystal structure of such complexes.
After completion of this manuscript, a paper by Calnan et al. (37) was published demonstrating that the glutamine residue in the basic domain of Tat is not required for trans-activation activity or binding to TAR. Their paper also shows that arginine-52 and -53 are more critical than arginine-55 and -56 for Tat activity. Our results are in agreement with these conclusions.
